Vaccine formulations in clinical development for the prevention of severe acute respiratory syndrome coronavirus 2 infection

The COVID-19 pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has led to an unprecedented effort toward the development of an effective and safe vaccine. Aided by extensive research efforts into characterizing and developing countermeasures towards prior coronavirus ep...

Descripción completa

Detalles Bibliográficos
Autores principales: Batty, Cole J., Heise, Mark T., Bachelder, Eric M., Ainslie, Kristy M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier B.V. 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7733686/
https://www.ncbi.nlm.nih.gov/pubmed/33316346
http://dx.doi.org/10.1016/j.addr.2020.12.006

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7733686/
https://www.ncbi.nlm.nih.gov/pubmed/33316346
http://dx.doi.org/10.1016/j.addr.2020.12.006

Ejemplares similares